Intuitive Surgical (NASDAQ:ISRG) Price Target Lowered to $480.00 at Evercore

Intuitive Surgical (NASDAQ:ISRGFree Report) had its target price trimmed by Evercore from $550.00 to $480.00 in a research note published on Monday morning,MarketScreener reports. The firm currently has a neutral rating on the medical equipment provider’s stock.

A number of other equities analysts have also weighed in on the company. HSBC increased their target price on Intuitive Surgical from $644.00 to $653.00 and gave the stock a “buy” rating in a research note on Monday, January 26th. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a research note on Tuesday, January 27th. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, Sanford C. Bernstein increased their target price on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research note on Friday, January 23rd. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $611.77.

View Our Latest Analysis on ISRG

Intuitive Surgical Stock Up 0.1%

NASDAQ:ISRG opened at $452.58 on Monday. The firm has a market capitalization of $160.72 billion, a price-to-earnings ratio of 57.36, a P/E/G ratio of 3.49 and a beta of 1.68. Intuitive Surgical has a 12-month low of $425.00 and a 12-month high of $603.88. The stock’s 50 day moving average price is $485.91 and its two-hundred day moving average price is $514.33.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last announced its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm’s quarterly revenue was up 18.8% compared to the same quarter last year. During the same quarter last year, the company earned $2.21 earnings per share. Equities research analysts expect that Intuitive Surgical will post 6.43 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Patricia L. Wadors sold 220 shares of the firm’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $493.95, for a total value of $51,864.75. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 32,943 shares of company stock worth $17,279,568. 0.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Intuitive Surgical

A number of large investors have recently modified their holdings of the business. Newbridge Financial Services Group Inc. boosted its holdings in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 33 shares in the last quarter. Holos Integrated Wealth LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $25,000. Olistico Wealth LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. Laurel Wealth Advisors LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $31,000. Finally, Turning Point Benefit Group Inc. boosted its holdings in shares of Intuitive Surgical by 833.3% during the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after acquiring an additional 50 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.

Featured Stories

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.